SCHEMBL25323979

SCHEMBL25323979

Cn1cc(Br)c(-c2ccncc2F)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 5/20 0.43
MAPK14 Q16539 4/20 0.43
MAPK11 Q15759 3/20 0.43
CSNK1E P49674 2/20 0.43
MAPK13 O15264 1/20 0.43
MAPK12 P53778 1/20 0.43
MAP4K4 O95819 1/20 0.39
EGFR P00533 1/20 0.39
FRK P42685 1/20 0.39
MAPK9 P45984 1/20 0.39
CSNK1A1 P48729 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
MELK Q14680 1/20 0.38
NUDT1 P36639 1/20 0.35
BRAF P15056 6/20 0.35
KCNH2 Q12809 1/20 0.35
AOC3 Q16853 1/20 0.35
MAPK3 P27361 1/20 0.34
MAPK1 P28482 1/20 0.34
ROCK2 O75116 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15885929 0.79 CYP11B1 (0.44) CSNK1DMAPK14MAPK11CSNK1EMAPK13
SCHEMBL2273627 0.79 LMNA (0.45)
SCHEMBL31352811 0.79 LMNA (0.45)
SCHEMBL31665009 0.76 HTR2A (0.41) CSNK1DMAPK14MAPK11CSNK1EMAPK13
SCHEMBL9933667 0.75 CSNK1D (0.69) CSNK1DMAPK14MAPK11CSNK1EMAPK13
SCHEMBL4128565 0.73 MAPK13 (0.54) CSNK1DMAPK14MAPK11CSNK1EMAPK13
SCHEMBL13874013 0.72 THRB (0.41) CSNK1DMAPK14CSNK1E
SCHEMBL30509498 0.72 CSNK1D (0.38) CSNK1DMAPK14MAPK11CSNK1EMAPK13
SCHEMBL30509504 0.71 BRAF (0.45) BRAF
SCHEMBL15884446 0.71 BRAF (0.45) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
EP-4214199-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 EP disclosed
CN-116490503-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS CSNK1D, CSNK1A1, CSNK2A1 CSNK1D 1/4885MAPK14 441/4885MAPK11 741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.